Qualigen Therapeutics, Inc.
Q2 2020 13F Holders
Symbol
QLGN
CUSIP
74754R103
Type
Equity
Class
COM
Num filers
14
Total reported value, excl. options
$441 k
Compare 2020 Q2 to
2022 Q3
2022 Q2
2022 Q1
2021 Q4
2021 Q3
2021 Q2
2021 Q1
2020 Q4
2020 Q3
Manager
Report Date
Value ($000)
Shares
Option Type